Cardioversion of uncomplicated paroxysmal atrial fibrillation: A survey of practice by Canadian emergency physicians

Canadian Journal of Emergency Medicine

Volumn 6, Issue 3, 2004, Pages 155-160

  Borgundvaag, Bjug ^a   Ovens, Howard ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardioversion; Emergency management; Paroxysmal atrial fibrillation

Indexed keywords

ARTICLE; CANADA; CARDIOVERSION; CERTIFICATION; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; HUMAN EXPERIMENT; MEDICAL PRACTICE; MEDICAL SOCIETY; QUESTIONNAIRE; RESIDENCY EDUCATION;

EID: 18344363409     PISSN: 14818035     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1481803500006849     Document Type: Article

References (29)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82(8A):2N-9N.
2. Yealy DM, Delbridge TR. Dysrhythmias. In: Marx JA, Hockberger RS, Walls RM, editors. Rosen's emergency medicine: concepts and clinical practic, vol 2. 5th ed. St. Louis (MO): Mosby; 2002. p. 1083-6.
3. Prystowsky EN, Benson DW Jr, Fuster V, Hart RG, Kay GN, Myerburg RJ, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology. American Heart Association. Circulation 1996;93(6):1262-77.
4. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38(4):1231-66.
5. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med 1995;333(1):5-10.
6. Michael JA, Stiell IG, Agarwal S, Mandavia DP. Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med 1999;33(4):379-87.
7. Dillman DA. Mail and Internet surveys: the tailored design method. 2nd ed. Toronto: John Wiley & Sons, Inc; 2000.
8. Godtfredsen J. Atrial fibrillation: etiology, course and prognosis: a follow-up study of 1212 cases. Copenhagen: Munksgaard; 1975.
9. Crozier IG, Ikram H, Kenealy M, Levy L. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Am J Cardiol 1987;59(6):607-9.
10. Crijns HJ, van Wijk LM, van Gilst WH, Kingma JH, van Gelder IC, Lie KI. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 1988;9(6):634-8.
11. Suttorp MJ, Kingma JH, Lie AHL, Mast EG. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63(11):693-6.
12. Suttorp MJ, Kingma JH, Jessurun ER, Lie AHL, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16(7):1722-7.
13. Gold RL, Haffajee CI, Charos G, Sloan K, Baker S, Alpert JS. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986;57(1):124-7.
14. Waris E, Kreus KE, Salokannel J. Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation. Acta Medica Scandinavica 1971;189(3):161-6.
15. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68(1):41-6.
16. Resnekov L, McDonald L. Appraisal of electroconversion in treatment of cardiac dysrhythmias. Br Heart J 1968;30(6):786-811.
17. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 1991;68(4):335-41.
18. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92(7):1954-68.
19. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94(7):1600-6.
20. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94(11):2968-74.
21. Daoud EG, Marcovitz P, Knight BP, Goyal R, Man KC, Strickberger SA, et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. Circulation 1999;99(23):3024-7.
22. Mattioli AV, Tarabini Castellani E, Vivoli D, Molinari R, Mattioli G. Restoration of atrial function after atrial fibrillation of different etiological origins. Cardiology 1996;87(3):205-11.
23. Khan IA. Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter. Am Heart J 2002;144(1):11-22.
24. Kapur AK. Emergency department treatment of paroxysmal atrial fibrillation [abstract]. Can J Emerg Med 2001;3(2):138.
25. Gosselink AT, Crijns HJ, van den Berg MP, van den Broek SA, Hillege H, Landsman ML, et al. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J 1994;72(2):161-6.
26. Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002;143(6):984-90.
27. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347(23):1825-33.
28. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent trial fibrillation. N Engl J Med 2002;347(23):1834-40.
29. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356(9244):1789-94.